UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 386

Sortiert nach

Interactions between cancer-associated fibroblasts and tumor cells promote MCL-1 dependency in estrogen receptor-positive breast cancers

Oncogene, 2019-04, Vol.38 (17), p.3261-3273

2019

Volltextzugriff (PDF)

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

Blood, 2001-12, Vol.98 (13), p.3527-3533

2001

Volltextzugriff (PDF)

The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma

Leukemia, 1998-12, Vol.12 (12), p.1977-1982

1998

Volltextzugriff (PDF)

Bcl-xL controls a switch between cell death modes during mitotic arrest

Cell death & disease, 2014-10, Vol.5 (10), p.e1429-e1429

2014

Volltextzugriff (PDF)

Zoledronate Is a Potent Inhibitor of Myeloma Cell Growth and Secretion of IL‐6 and MMP‐1 by the Tumoral Environment

Journal of bone and mineral research, 1999-12, Vol.14 (12), p.2048-2056

1999

Volltextzugriff (PDF)

Bcl-xL controls a switch between cell death modes during mitotic arrest

Cell death & disease, 2014-06, Vol.5 (6), p.e1291-e1291

2014

Volltextzugriff (PDF)

Impact of XIAP protein levels on the survival of myeloma cells

Haematologica (Roma), 2009-01, Vol.94 (1), p.87-93

2009

Volltextzugriff (PDF)

Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization

Cancer research (Chicago, Ill.), 1995-08, Vol.55 (16), p.3647-3653

1995

Volltextzugriff (PDF)

Myeloma Cells Upregulate Interleukin-6 Secretion in Osteoblastic Cells Through Cell-to-Cell Contact But Downregulate Osteocalcin

Blood, 1995-10, Vol.86 (8), p.3151-3159

1995

Volltextzugriff (PDF)

Significant impact of survivin on myeloma cell growth

Leukemia, 2007-05, Vol.21 (5), p.1070-1078

2007

Volltextzugriff (PDF)

Production of Metalloproteinase-7 (Matrilysin) by Human Myeloma Cells and Its Potential Involvement in Metalloproteinase-2 Activation

The Journal of immunology (1950), 1999-11, Vol.163 (10), p.5723-5728

1999

Volltextzugriff (PDF)

Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy

Leukemia, 1999-02, Vol.13 (2), p.289-294

1999

Volltextzugriff (PDF)

IL-6 UPREGULATES ITS OWN RECEPTOR ON SOME HUMAN MYELOMA CELL LINES

Cytokine (Philadelphia, Pa.), 2001-06, Vol.14 (6), p.352-356

2001

Volltextzugriff (PDF)

Fluoroquinolone Use and Fluoroquinolone Resistance: Is There an Association?

Clinical infectious diseases, 1994-07, Vol.19 (1), p.54-59

1994

Volltextzugriff (PDF)

Human myeloma cells stimulate the receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease

Blood, 2002-12, Vol.100 (13), p.4615-4621

2002

Volltextzugriff (PDF)

Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasone

Blood, 1996-12, Vol.88 (12), p.4659-4666

1996

Volltextzugriff (PDF)

CD130 rather than CD126 expression is associated with disease activity in multiple myeloma

British journal of haematology, 1999-08, Vol.106 (2), p.532-535

1999

Volltextzugriff (PDF)

CD28, a marker associated with tumoral expansion in multiple myeloma

Clinical cancer research, 1998-06, Vol.4 (6), p.1521-1526

1998

Volltextzugriff (PDF)

Metalloproteinases in multiple myeloma : Production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells

Blood, 1997-08, Vol.90 (4), p.1649-1655

1997

Volltextzugriff (PDF)

Regulation of Cancer Cell Survival by BCL2 Family Members upon Prolonged Mitotic Arrest: Opportunities for Anticancer Therapy

Anticancer research, 2012-10, Vol.32 (10), p.4225-4233

2012

Volltextzugriff (PDF)

The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma

European cytokine network (Montrouge), 2000-12, Vol.11 (4), p.546

2000

Volltextzugriff (PDF)

Cell cycle and cell death associates in western France

Cell death and differentiation, 2007-05, Vol.14 (5), p.1066-1067

2007

Volltextzugriff (PDF)

The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy

Haematologica (Roma), 2006-09, Vol.91 (9), p.1234-1240

2006

Volltextzugriff (PDF)

Metalloproteinases in Multiple Myeloma: Production of Matrix Metalloproteinase-9 (MMP-9), Activation of proMMP-2, and Induction of MMP-1 by Myeloma Cells

Blood, 1997-08, Vol.90 (4), p.1649-1655

1997

Volltextzugriff (PDF)

Turbulence and Related Phenomena

Barillé, Régis

2019

Volltextzugriff (PDF)

1 – 25 von 386

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(347)
Mit Volltextzugriff
(369)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(255)
Life Sciences & Biomedicine
(139)
Physical Sciences
(129)
Physics
(71)
Technology
(63)
Humans
(60)
Biological And Medical Sciences
(58)
Life Sciences
(57)
Marine & Freshwater Biology
(49)
Environmental Sciences
(44)
Environmental Sciences & Ecology
(41)
Materials Science
(40)
Optics
(37)
Chemistry
(34)
Fundamental And Applied Biological Sciences. Psychology
(34)
Marine
(33)
Crassostrea Gigas
(32)
Animal, Plant And Microbial Ecology
(30)
Materials Science, Multidisciplinary
(30)
Oceanography
(29)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Interactions between cancer-associated fibroblasts and tumor cells promote MCL-1 dependency in estrogen receptor-positive breast cancers

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma

Bcl-xL controls a switch between cell death modes during mitotic arrest

Zoledronate Is a Potent Inhibitor of Myeloma Cell Growth and Secretion of IL‐6 and MMP‐1 by the Tumoral Environment

Bcl-xL controls a switch between cell death modes during mitotic arrest

Impact of XIAP protein levels on the survival of myeloma cells

Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization

Myeloma Cells Upregulate Interleukin-6 Secretion in Osteoblastic Cells Through Cell-to-Cell Contact But Downregulate Osteocalcin

Significant impact of survivin on myeloma cell growth

Production of Metalloproteinase-7 (Matrilysin) by Human Myeloma Cells and Its Potential Involvement in Metalloproteinase-2 Activation

Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy

IL-6 UPREGULATES ITS OWN RECEPTOR ON SOME HUMAN MYELOMA CELL LINES

Fluoroquinolone Use and Fluoroquinolone Resistance: Is There an Association?

Human myeloma cells stimulate the receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease

Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasone

CD130 rather than CD126 expression is associated with disease activity in multiple myeloma

CD28, a marker associated with tumoral expansion in multiple myeloma

Metalloproteinases in multiple myeloma : Production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells

Regulation of Cancer Cell Survival by BCL2 Family Members upon Prolonged Mitotic Arrest: Opportunities for Anticancer Therapy

The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma

Cell cycle and cell death associates in western France

The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy

Metalloproteinases in Multiple Myeloma: Production of Matrix Metalloproteinase-9 (MMP-9), Activation of proMMP-2, and Induction of MMP-1 by Myeloma Cells

Turbulence and Related Phenomena

Suchergebnisse filtern